Log In
Print
BCIQ
Print
Print this Print this
 

Orthokine

  Manage Alerts
Collapse Summary General Information
Company Orthogen AG
DescriptionAutologous injection of interleukin-1 (IL-1) receptor antagonist protein
Molecular Target Interleukin-1 (IL-1) receptor antagonist (IL-1RA)
Mechanism of ActionInterleukin-1 (IL-1) receptor antagonist
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat chronic knee pain due to osteoarthritis (OA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today